News | November 15, 2013

Hospital in Spain First to Treat Skin Cancer Patients With Esteya Electronic Brachytherapy System

Hospital La Fe's study demonstrates patient-friendliness, short procedure time with Esteya

radiation therapy brachytherapy nucletron elekta esteya hospital la fe
November 15, 2013 — Hospital La Fe, a clinical collaborator of Nucletron, an Elekta company, is nearing the conclusion of the enrollment phase of a clinical study with the Esteya electronic brachytherapy system for treating skin cancer. First clinical data on efficacy are expected in about two months, but physicians in the center's radiotherapy department are already reporting that patients have tolerated the treatments well and that the system is user-friendly.
 
The enrollment of the first group of 20 patients ever to receive treatment with Esteya, was completed in October. The center is using a standard treatment protocol of 36.6 Gy over six fractions, 6.1 Gy per fraction delivered twice weekly.
 
"The patients have accepted the treatment very well and side effects reported for the first treated patients have been very mild — typically just little skin reddening or itching," said José Perez-Calatayud, head of medical physics, Hospital La Fe. "The treatment delivery times have averaged less than three minutes per lesion, for a total treatment session of seven to eight minutes. This short therapy delivery is important, certainly, for patients with multiple lesions. One of the patients we treated had nine lesions."
 
"With five surface applicators ranging in size from 1 cm to 3 cm, we have a great opportunity to adapt to the lesion's size, thus helping us avoid exposing normal tissue," said Perez-Calatayud. "And the leakage dose — the dose outside the volume to be treated — is extremely low due to the combination of low energy and tungsten shielding of the applicators."
 
Planning and delivery of electronic brachytherapy at Hospital La Fe has been exceptionally straightforward.
 
"The graphical user interface is uncomplicated and patient setup is quite simple, contributing to a smooth, efficient workflow," said Perez-Calatayud.
 
For more information: www.esteya.com

Related Content

Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
RaySearch Launches RayCare Oncology Information System

Image courtesy of RaySearch Laboratories

Technology | Oncology Information Management Systems (OIMS) | December 22, 2017
RaySearch announced the first release of RayCare, a new oncology information system (OIS) designed to connect the...
RaySearch Releases RayStation 7 Radiotherapy Treatment Planning System
Technology | Treatment Planning | December 19, 2017
RayStation 7, the latest release of RaySearch’s radiation therapy treatment planning system, adds new functionality and...
Overlay Init